We are live on
!
Find out more
RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.7B
1-Year Est. Return
93.03%
This Fund
S&P 500
This Quarter
Est. Return
-8.24%
1 Year Est. Return
+93.03%
3 Year Est. Return
+228.43%
5 Year Est. Return
+368.14%
10 Year Est. Return
+4,607.77%
AUM
$3.44B
AUM Growth
-$537M
(-14%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
35%
Holding
141
New
7
Increased
68
Reduced
12
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$42.4M |
| 2 |
Penumbra
PEN
|
+$31.3M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$26.2M |
| 4 |
Humana
HUM
|
+$25.7M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$18.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$94M |
| 2 |
Encompass Health
EHC
|
+$35.7M |
| 3 |
iRhythm Holdings
IRTC
|
+$22M |
| 4 |
XENT
Intersect ENT, Inc
XENT
|
+$15.4M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.57% |
| 2 | Consumer Staples | 0.96% |
| 3 | Industrials | 0.47% |
| 4 | Financials | 0.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
126
Amarin Corp
AMRN
$298M
| – | – |
-220,985
| Closed | -$14.5M |
|
|
LONA
127
LeonaBio Inc
LONA
$70.5M
| – | – |
-55,225
| Closed | -$7.46M |
|
128
Cullinan Oncology
CGEM
$1.18B
| – | – |
-652,578
| Closed | -$6.83M |
|
|
129
Encompass Health
EHC
$12.5B
| – | – |
-631,643
| Closed | -$35.7M |
|
|
130
HCA Healthcare
HCA
$89.6B
| – | – |
-375,000
| Closed | -$94M |
|
|
131
Rigel Pharmaceuticals
RIGL
$778M
| – | – |
-492,149
| Closed | -$14.7M |
|
132
Shattuck Labs
STTK
$682M
| – | – |
-313,499
| Closed | -$1.34M |
|
|
LENZ
133
LENZ Therapeutics
LENZ
$168M
| – | – |
-255,822
| Closed | -$9.13M |
|
|
PSTX
134
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| – | – |
-289,754
| Closed | -$1.3M |
|
|
XENT
135
DELISTED
Intersect ENT, Inc
XENT
| – | – |
-550,000
| Closed | -$15.4M |
|
Similar funds
ACM
BCM
PP
GAM
FACM
RMC
JIP
II
Rock Springs Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Rock Springs Capital Management held 141 positions worth $3.44B, down 14% from $3.97B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rock Springs Capital Management's Q2 2022 filing shows 7 new, 68 increased, 12 reduced and 10 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 200,000 shares worth $25.6M. The largest sale was HCA Healthcare, an estimated $94M.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 95% a quarter earlier, followed by Consumer Staples and Industrials.
- Rock Springs Capital Management's largest Q2 2022 buy was State Street Health Care Select Sector SPDR ETF: 200,000 shares worth $25.6M.
- Rock Springs Capital Management added most to Align Technology in Q2 2022, an estimated $42.4M increase.
- Rock Springs Capital Management's biggest Q2 2022 reduction was iRhythm Holdings, cutting an estimated $22M.
- Rock Springs Capital Management fully exited HCA Healthcare in Q2 2022, selling an estimated $94M.
- Rock Springs Capital Management's ten largest holdings make up 35% of its $3.44B portfolio in Q2 2022.
- Rock Springs Capital Management opened 7 new positions and closed 10 in Q2 2022.
- Rock Springs Capital Management's portfolio value fell 14% quarter-over-quarter to $3.44B.
Based on Rock Springs Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.